"We anticipate providing updated emavusertib clinical data" from the PCNSL TakeAim Lymphoma combination study "in the first half of 2027" and said Curis is aiming for accelerated submissions in the ...

Jordan Peterson’s disappearance from the public eye has led to persistent speculation the celebrity shrink’s journey into fringe online wellness fads contributed to his decline. In recent years the ...

Canadian AI startup Cohere is taking over Germany-based Aleph Alpha, with the blessing of their governments, in a bid to offer a sovereign alternative to enterprises in an AI landscape dominated by ...

Canadian AI lab Cohere has announced plans to acquire German AI startup Aleph Alpha. Schwarz Group — a key backer of Aleph Alpha — plans to invest $600 million in Cohere's upcoming Series E round as ...

Time-limited acalabrutinib plus venetoclax improves outcomes vs chemoimmunotherapy, offering the first FDA-approved all-oral fixed-duration CLL option, explains Adam Kittai, MD. The study compared ...

In "Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels continue their conversation on communicating ...

Eli Lilly has chalked up another victory in the chronic lymphocytic leukemia (CLL) space, as its BTK inhibitor Jaypirca delivered its fourth positive phase 3 readout in the blood cancer. Monday, Lilly ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

Our Verdict: DirectMeds offers one of the most accessible NAD+ injection programs in the telehealth space. With LegitScript certification, 180,000+ customers, a 4.6-star Trustpilot rating, and ...

James Dentzer, President and CEO, stated that "we continue to make steady progress in our TakeAim Lymphoma study in primary CNS lymphoma, one of the most rare and most difficult to treat of the NHL ...